Search

Author/Creator Concas, Laura

1. Everolimus treatment for neuroendocrine tumors: latest results and clinical potential. (March 2017)

Authors:
Pusceddu, Sara; Verzoni, Elena; Prinzi, Natialie; Mennitto, Alessia; Femia, Daniela; Grassi, Paolo; Concas, Laura; Vernieri, Claudio; Lo Russo, Giuseppe; Procopio, Giuseppe
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 9:Number 3(2017:May)
Page Start:
183
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Evolution in the treatment of gastroenteropancreatic-neuroendocrine neoplasms, focus on systemic therapeutic options: a systematic review. (July 2015)

Authors:
Pusceddu, Sara; De Braud, Filippo; Festinese, Fabrizio; Bregant, Cristina; Lorenzoni, Alice; Maccauro, Marco; Milione, Massimo; Concas, Laura; Formisano, Barbara; Leuzzi, Livia; Mazzaferro, Vincenzo; Buzzoni, Roberto
Journal:
Future oncology
Issue:
Volume 11:Number 13(2015)
Page Start:
1947
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes. (May 2016)

Authors:
Pusceddu, Sara; Buzzoni, Roberto; Vernieri, Claudio; Concas, Laura; Marceglia, Sara; Giacomelli, Luca; Milione, Massimo; Leuzzi, Livia; Femia, Daniela; Formisano, Barbara; Mazzaferro, Vincenzo; de Braud, Filippo
Journal:
Future oncology
Issue:
Volume 12:Number 10(2016)
Page Start:
1251
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors. (25th May 2017)

Authors:
Berardi, Rossana; Torniai, Mariangela; Pusceddu, Sara; Spada, Francesca; Ibrahim, Toni; Brizzi, Maria Pia; Antonuzzo, Lorenzo; Ferolla, Piero; Panzuto, Francesco; Silvestris, Nicola; Partelli, Stefano; Ferretti, Benedetta; Freddari, Federica; Gucciardino, Calogero; Testa, Enrica; Concas, Laura; M...
Journal:
Cancer medicine
Issue:
Volume 6:Number 7(2017:Jul.)
Page Start:
1493
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors. (August 2017)

Authors:
Pusceddu, Sara; Prinzi, Natalie; Lo Russo, Giuseppe; Femia, Daniela; Milione, Massimo; Perrone, Federica; Tamborini, Elena; Concas, Laura; Pulice, Iolanda; Vernieri, Claudio; Corti, Francesca; Buzzoni, Roberto; de Braud, Filippo
Journal:
Future oncology
Issue:
Volume 13:Number 19(2017)
Page Start:
1677
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Rationale and protocol of the MetNET-1 trial, a prospective, single center, phase II study to evaluate the activity and safety of everolimus in combination with octreotide LAR and metformin in patients with advanced pancreatic neuroendocrine tumors. Issue 6 (November 2014)

Authors:
Pusceddu, Sara; de Braud, Filippo; Concas, Laura; Bregant, Cristina; Leuzzi, Livia; Formisano, Barbara; Buzzoni, Roberto
Journal:
Tumori
Issue:
Volume 100:Issue 6(2014)
Page Start:
e286
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Update on medical treatment of small intestinal neuroendocrine tumors. Issue 9 (1st September 2016)

Authors:
Pusceddu, Sara; Femia, Daniela; Lo Russo, Giuseppe; Ortolani, Silvia; Milione, Massimo; Maccauro, Marco; Vernieri, Claudio; Prinzi, Natalie; Concas, Laura; Leuzzi, Livia; De Braud, Filippo; Buzzoni, Roberto
Journal:
Expert review of anticancer therapy
Issue:
Volume 16:Issue 9(2016)
Page Start:
969
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗